WHO Refutes Alleged Link Between Paracetamol Use in Pregnancy and Autism

BRUSSELS – The World Health Organization (WHO) clarified on Wednesday that current scientific findings do not support any definitive connection between the use of paracetamol during pregnancy and the risk of autism spectrum disorder (ASD). This statement counters recent assertions made by US President Donald Trump.

According to WHO, approximately 62 million individuals globally, or one in every 127 people, are affected by ASD, a complex group of neurodevelopmental conditions. While diagnostic methods and awareness have improved, the precise causes of autism remain uncertain and likely involve multiple factors.

President Trump recently suggested that taking Tylenol, known internationally as paracetamol, during pregnancy may significantly increase the likelihood of a child developing autism. However, the WHO emphasized that extensive research conducted over the last ten years, incorporating large population studies, has found no consistent evidence linking prenatal paracetamol exposure to autism.

Moreover, the organization reaffirmed that comprehensive scientific data conclusively disproves any association between childhood vaccinations and autism, citing numerous studies across various countries that have also debunked claims involving vaccine components such as thiomersal or aluminum.

WHO Director-General Tedros Adhanom Ghebreyesus advised expectant mothers on the social media platform X to adhere strictly to medical guidance when considering medication use during pregnancy, particularly during the first trimester, and to exercise caution with all drugs.

The WHO's message underscores the importance of relying on robust scientific evidence and maintaining public confidence in proven healthcare practices.